Home About CHIPSA Facilities Location Treatments Research FAQs Blog Contact Us Admissions

Living Legacy: The ‘Official’ Gerson Hospital

Within the context of modern science and medicine CHIPSA offers the immunonutritional and detoxification treatments developed by Max B. Gerson, MD. The Gerson legacy is our CHIPSA story.

For more than twenty-six years, the medical teams at CHIPSA have used a hospital treatment environment as the primary venue for the study, development and refinement of the Gerson imuno-nutrition protocol and the original detoxification treatment.

Today, Gerson’s+Therapy is the foundation upon which all modern immunonutrition therapies are developed upon according to modern medical analysis and applications worldwide.

Write to us
Connect with a Doctor
ImmunoTherapy Article

The Gerson diet-therapy for cancer is an intensive proven, immunological detoxification and nutrition protocol. Macronutrient manipulation in the context of micronutrient supplementation has been proven to stimulate immunity and promote tissue integrity. It works closely with the healing forces of nature to stimulate tissue repair and normal growth through the input of more fresh, raw vegetable materials than any other nutritional intervention. Fresh juice, raw fruits and vegetables are the source materials of almost all micronutrients in their pristine organic composition.

Although the diet includes raw and cooked foods in its three daily vegan meals, extraordinary amounts of unaltered foods are consumed as well as the intravenous inclusion of vitamin drips. Specific fruits and vegetables, both raw and freshly prepared, and their raw juices supply enormous quantities of many phytochemicals currently under study worldwide for exciting anticancer and health promoting properties. Moreover, the use of raw foods ensures that patients receive even those health-promoting factors.

Oncological diet therapy is a medical specialty, not unlike oncological radiotherapy. In many instances diet therapy will be sufficient to cause complete regression of cancer. CHIPSA clinical scientists believe that complementary use of medical specialties will lead to more satisfactory overall outcomes when complementary medical protocols (such as Coley Toxin, Issel protocols and photopheresis) are co-implemented.

Results are continually published in peer review medical environments and with Internet medical journals and literature under the Gerson Research Organization at the The Gerson Hospital, CHIPSA Medical Center, The Center for Integrative Medicine and Research and international medical related entities.

To this end, the CHIPSA Hospital enrolls all patients (who wish to participate for a small fee reduction for their treatment) in clinical studies conducted and outcomes reported.

Top of page





- - - -